Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Antiserum, Digoxin

FDA product code DKA · 3 cleared devices

Class 2 Clinical Toxicology
Regulation
21 CFR 862.3320
Review panel
TX
Implant
No
Life sustaining
No
Third party review
Yes
GMP exempt
No
Clearance span
1978-03-17 – 1994-11-22
↑